MENU
GOVX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

GeoVax Labs (GOVX) Earnings Date & Reports

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more

A.I. Advisor
published Earnings

GOVX is expected to report earnings to rise 5.15% to -101 cents per share on November 12

GeoVax Labs GOVX Stock Earnings Reports
Q3'26
Est.
$-1.02
Q2'26
Beat
by $1.30
Q1'26
Missed
by $2.08
Q4'25
Missed
by $2.27
Q3'25
Missed
by $0.02
The last earnings report on July 27 showed earnings per share of -97 cents, beating the estimate of -226 cents. With 179.54K shares outstanding, the current market capitalization sits at 1.44M.